← Back to Screener
Bluejay Diagnostics, Inc. Common Stock (BJDX)
Price$1.97
Favorite Metrics
Price vs S&P 500 (26W)-93.07%
Price vs S&P 500 (4W)-10.48%
Market Capitalization$1.94M
All Metrics
Book Value / Share (Quarterly)$39.54
P/TBV (Annual)0.33x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-41.21
Price vs S&P 500 (YTD)-29.23%
EPS (TTM)$-65.48
10-Day Avg Trading Volume0.02M
EPS Excl Extra (TTM)$-65.48
EPS (Annual)$-61.01
ROI (Annual)-114.43%
Gross Margin (Annual)20.00%
Cash / Share (Quarterly)$34.18
ROA (Last FY)-96.20%
Revenue Growth TTM (YoY)-100.00%
EBITD / Share (TTM)$-30.11
ROE (5Y Avg)-138.17%
Cash Flow / Share (Annual)$-41.21
P/B Ratio0.33x
P/B Ratio (Quarterly)0.20x
Net Income / Employee (Annual)$-1
Net Interest Coverage (TTM)-10.40x
ROA (TTM)-115.63%
EPS Incl Extra (Annual)$-61.01
Current Ratio (Annual)4.88x
Quick Ratio (Quarterly)4.64x
3-Month Avg Trading Volume0.16M
52-Week Price Return-77.38%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$4.21
P/S Ratio (Annual)7.78x
Asset Turnover (Annual)0.02x
52-Week High$16.68
EPS Excl Extra (Annual)$-61.01
CapEx CAGR (5Y)98.32%
26-Week Price Return-84.33%
Quick Ratio (Annual)4.64x
13-Week Price Return-23.37%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)4.88x
Enterprise Value$-3.211
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-3720.00%
Cash / Share (Annual)$34.18
3-Month Return Std Dev99.61%
Net Income / Employee (TTM)$-1
ROE (Last FY)-114.61%
Net Interest Coverage (Annual)-3.84x
EPS Basic Excl Extra (Annual)$-61.01
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-65.48
ROI (TTM)-145.19%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$11.42
Price vs S&P 500 (52W)-112.47%
Year-to-Date Return-25.09%
5-Day Price Return13.64%
EPS Normalized (Annual)$-61.01
ROA (5Y Avg)-100.39%
Net Profit Margin (Annual)-3720.00%
Month-to-Date Return8.70%
Cash Flow / Share (TTM)$-9.03
EBITD / Share (Annual)$-61.21
Operating Margin (Annual)-3824.00%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-137.64%
LT Debt / Equity (Quarterly)0.25x
EPS Basic Excl Extra (TTM)$-65.48
P/TBV (Quarterly)0.73x
P/B Ratio (Annual)0.20x
Book Value / Share (Annual)$39.54
Price vs S&P 500 (13W)-26.24%
Beta0.84x
Revenue / Share (TTM)$0.00
ROE (TTM)-145.52%
52-Week Low$1.65
Analyst Recommendations
Apr 2024
May 2024
Jun 2024
Jul 2024
2.17
2.17
2.17
2.17
Industry Peers — Surgical & Medical Instruments(109)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
BJDXBluejay Diagnostics, Inc. Common Stock | — | — | — | — | $1.97 |
SYKStryker Corporation | 5.17x | 11.84% | 64.57% | 19.43% | $338.34 |
BSXBoston Scientific Corp. | 4.58x | 15.16% | 69.01% | 18.00% | $60.99 |
MMM3M Company | 3.21x | -4.97% | 39.92% | 18.55% | $151.40 |
MDLNMedline Inc. Class A common stock | 2.20x | — | 26.44% | 7.78% | $48.26 |
BDXBecton, Dickinson and Co. | 2.06x | 6.32% | 46.42% | 12.15% | $158.64 |
RMDResMed Inc. | 6.07x | 11.72% | 60.85% | 33.70% | $226.14 |
DXCMDexCom, Inc. | 5.33x | 19.33% | 62.09% | 19.56% | $64.62 |
WSTWest Pharmaceutical Services, Inc. | 6.29x | 7.44% | 35.91% | 19.03% | $278.00 |
PODDInsulet Corporation | 5.19x | 24.53% | 71.63% | 12.92% | $200.87 |
PENPenumbra, Inc. | 9.24x | 20.16% | 67.14% | 13.48% | $329.71 |
About
Bluejay Diagnostics develops the Symphony System, a rapid, cost-effective near-patient testing platform for sepsis diagnosis and monitoring. Its first product, an IL-6 sepsis test, delivers results in approximately 20 minutes, enabling faster clinical decision-making and improved patient outcomes. The platform addresses a critical clinical need in acute care settings where rapid sepsis diagnosis is essential for treatment efficacy.